by Alyssa Lee | Aug 31, 2026
DelRicht Research is conducting a weight management study for adults with type 2 diabetes using a GLP-1. Compensation for time and travel may be provided. This study is evaluating a new GLP-1 medication option. GLP-1 hormone receptors are found throughout the body,...
by Alyssa Lee | Aug 31, 2026
DelRicht Research is conducting a Shingles Vaccine study. Compensation for time and travel may be provided. Enrollment begins in mid September! Shingles develops from Herpes Zoster, the same virus that causes chicken pox. It causes body aches, headaches, and a painful...
by Alyssa Lee | Aug 31, 2026
DelRicht Research is conducting a Migraine research study. Compensation for time and travel may be provided. Fast Facts Migraines are the third most common health condition in the world, affecting the lives of millions. There are many different sub-types of migraines...
by Alyssa Lee | Aug 31, 2026
DelRicht Research is conducting a male pattern baldness research study. Compensation for time and travel may be provided. Androgenetic Alopecia, more commonly known in men as Male Pattern Baldness, is a common form of hair loss that affects an estimated 50 million men...
by Alyssa Lee | Aug 31, 2026
Delricht Research is conducting a Low Testosterone & Infertility research study. Compensation for time and travel may be provided. An individual’s healthy levels of testosterone will vary from person to person, but changes in hormone levels over time can...
